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Background/aim: The aim of this study is to compare clinical and oncologic outcomes of the high and low ligation techniques of the
inferior mesenteric artery (IMA) in rectal cancer patients treated with robotic surgery after neoadjuvant chemoradiotherapy (nCRT).
Materials and methods: In this retrospective study, 77 patients with T3/T4-node negative rectal cancer with tumor penetration through
the muscle wall (Stage 2) or node positive disease without distant metastases (Stage 3) who were treated electively with robotic surgical
resection following nCRT at a single institution between January 2014 and January 2018 were analyzed. Patients were divided into 2
groups (38 patients were included in the low ligation group and 39 patients in the high ligation group).
Results: There was no statistical difference between the high ligation group and low ligation group in univariate analysis for 2-year
overall survival and disease-free survival (OR = 1.146; 95% CI = 0.274 to 4.797; P = 0.950, and OR = 1.141; 95% CI = 0.564 to 2.308;
P = 0.713, respectively). There was no significant difference between the 2 groups in the mean number of harvested lymph nodes and
mean number of metastatic lymph nodes (P = 0.980 and P = 0.124, respectively). Anastomosis stricture was observed significantly less
frequently in the low ligation group versus the high ligation group (2.6% and 28.2%, respectively) (P = 0.002). Also, the difference for
the median length of hospital stay for the high and low ligation groups was statistically significant in favor of the low ligation group (P
= 0.011).
Conclusion: In robotic rectal surgery, the low ligation technique of the IMA can reduce the rate of anastomosis stricture and provide
similar oncological results as the high ligation technique.
Key words: Rectal cancer, anastomosis stricture, inferior mesenteric artery, low ligation, robotic surgery, lymphadenectomy

1. Introduction
Colorectal canceris the 3rd most common cancer and the
4th most common cause of cancer-related deaths in the
world [1]. Local recurrence rates for rectal cancer have
even been reported as 20%–45% worldwide[2]. Several
advances in surgical techniques such as total mesorectal
excision (TME) reported by Heald and Ryall [3] and
segmental resection of the tumor along with the en bloc
associated lymphatic and vascular supply have remarkably
improved clinical outcomes in patients with rectal cancer
over the past decades [4]. The understanding of “en bloc
lymph node resection to the origin level of the primary
supply vessels” has been accepted as an important stage
in this treatment [5]. More specifically, ligation of the
root of the inferior mesenteric artery (IMA) proximal to
the left colic artery (LCA) bifurcation (high ligation) is
considered mandatory for wide lymph node dissection[6].

The rational for this is that it allows more adequate lymph
node resection due to more extensive dissection around
the root of the IMA. An extensive mobilization of the left
colon may be more possible by the transection of the IMA
at the root of abdominal aorta and can allow a tensionfree and safer colorectal anastomosis. However, there is no
consensus on the optimal level of ligation [4]because no
difference in oncologic outcomes has been observed yet
between high (proximal to the LCA bifurcation) and low
(distal to the LCA bifurcation) ligation of the IMA[7,8].
However, some negative clinical results caused by high
ligation are also mentioned in the literature. Hinoi et al.
suggested that the high ligation of IMA in the laparoscopic
abdominal resection for middle and low rectal cancer is
associated with higher anastomotic leak rates [9]. Komen
et al. also claimed, by showing higher blood flow rates
in the low ligation group, that anastomosis would be
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better perfused in this group [10]. In addition, Sciuto et
al. mentioned that reduced blood flow raises concern for
colonic ischemia and an increased risk of anastomotic
leak [11], but there are conflicting observations between
studies. Some studies have mentioned early morbidities
such as anastomosis leakage. However, long-term clinical
results have not been mentioned, and patients could not
be standardized for surgical procedures, tumor stages,
tumor localizations, and neoadjuvant therapies.
Since the first robotic colon surgery was performed
by Weber et al. [12], several reports have presented
more beneficial clinical and oncological outcomes of
robotic surgery for rectal cancers [13–16]. Thus, robotic
systems have started to be used more widely, especially
in minimally invasive colorectal surgery. Robotic surgery
systems (da Vinci Surgical System, Intuitive Surgical Inc.,
Sunnyvale, California, CA, USA) have 3-dimensional
(3D), enhanced high definition vision. In addition, the
EndoWrist instruments (Intuitive Surgical, Inc.) of the
system, the surgeon-controlled camera platform, and
stable traction provided by the robotic arm provide
surgeons with a range of motion far superior to that of the
human hand and thus help surgeons to perform a more
precise dissection in the pelvic cavity.
This study was designed to present the postoperative
complications and 2-year survival rates of 77 consecutive
patients with rectal cancer who underwent neoadjuvant
chemoradiotherapy (nCRT) and robotic surgery with the
high ligation and low ligation of the IMA.
2. Materials and methods
2.1. Patients selection and characteristics of the study
In this retrospective study, we evaluated 357 consecutive
patients with rectal cancer who underwent open,
laparoscopic, and robotic surgery. We only included rectal
cancer patients who underwent robotic TME resection
with the da Vinci XI Surgical System following nCRT at a
single institution between January 2014 and January 2018.
Finally, we identified 77 patients treated electively with
robotic surgical resection of rectal cancer following nCRT
with primary anastomosis and loop ileostomy (Figure 1).
All patients underwent a preoperative colonoscopic
evaluation to determine the localization of the tumor and
also abdominal and pelvic computed tomography (CT)
or magnetic resonance imaging (MRI) for preoperative
staging. None of the patients had preoperative whole gut
cleaning. Patients received only 2 rectal enemas in the
morning of the surgery.
Baseline covariates of the patients included age, sex,
comorbidities, American Anesthesiology Association
(ASA) classification, postoperative complications,
previous abdominal surgical interventions, and length of
hospital stay.
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Patients with T3/T4-node negative rectal cancer with
tumor penetration through the muscle wall or node positive
disease without distant metastases had combined-modality
therapy. nCRTwas performed as long course radiotherapy
at 50.4Gy, concurrent with a fluoropyrimidine-based
radiosensitizing chemotherapeutic agent (capacitabine
or 5-FU). One or two cycles of induction chemotherapy
after nCRT were performed in a period of 8 to 10 weeks
until surgery. Induction chemotherapies were CapOx
(capacitabineoxaliplatin) or FOLFOX (folinic acid-5fluorouracil-oxaliplatin) and were followed by surgery.All
patients received 6 cycles of adjuvant chemotherapy in the
postoperative period.
Morbidities were defined as complications (e.g.,
anastomotic strictures, anastomotic leaks, surgical site
infections, ileus, rectovaginal fistula, postoperative
intraabdominal bleeding, uretheral injury, pulmonary
embolism, and reoperation) that involved additional
treatment or a prolonged hospital stay. Anastomotic
stricture was defined as not allowing the passage of the
colonoscope or allowing the passage but requiring a digital
or balloon dilatation.
Tumour node metastasis (TNM) classification of the
8th edition of the American Joint Committee on Cancer
(AJCC), tumor localization, number of harvested lymph
nodes, number of metastatic lymph nodes, and the ratio of
metastatic lymph node number to harvested lymph nodes
were determined as tumor characteristics.
Patients were treated by only 1 surgeon specialized
in colorectal surgery. This surgeon was also trained and
certified as an expert in the da Vinci Surgical System.
Patients were regularly followed up at an outpatient
clinic. History taking and physical examination were
conducted every 3 months for 1 year, then every 6
months for 2 years and, finally, on an annual basis.
Control colonoscopy was performed in the 2nd month
after adjuvant treatment was completed to close the loop
ileostomy. Complications such as stricture, fistula, and
dissociation in anastomosis were noted. If no problem
was detected in the anastomosis, the loop ileostomy was
closed. Abdominal and pelvic CT scans were performed
annually for up to 3 years.The mean follow-up time for the
high ligation group and the low ligation group was 33.03
± 6.9 (range: 24–48) weeks and 33.76 ± 6.6 (range: 24–46)
weeks, respectively.The study was approved by the local
ethics committee (2020-2040).
2.2. Surgical procedure and ligation of the inferior
mesenteric artery
The da Vinci Xi Surgical System was used for the surgical
procedure and the 5-port technique was used for the
docking method.Patients were grouped into 2 intervention
groups: as the high ligation group if the IMA was divided
proximal to the left colic artery bifurcation and in the low
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Patients with rectal cancer treated with open,
laparoscopic and robotic surgery
357
Patients excluded that treated with open and
laparoscopic surgery
268
Converting open surgery
2
Patients with rectal cancer treated with robotic
surgery
87
Patients with rectal cancer treated with robotic
surgery nonfollowing NCRT
8
Patients with rectal cancer treated with robotic
surgery following NCRT
79
Patients with rectal cancer treated with robotic
surgery without loop ileostomy
2
Patients with rectal cancer treated with robotic
surgery following NCRT with loop ileostomy
77

High Ligation Group
38

Low Ligation Group
39

Figure 1. Election of the study groups.

ligation group if the IMA was divided distal to the left colic
artery bifurcation. The decision about the level of IMA
ligation was made by the surgeon. The TME resection
technique was performed in all patients. The robotic
dissection for TME was as follows: a) the origin of the
IMA from the abdominal aorta and the LCA bifurcation
was explored. Lymphoadipose tissues around this area
were skeletonized to perform complete D3 lymph node
dissection, and the sympathetic nerve plexus surrounding
the IMA was preserved; b) the LCA and superior rectal
artery were identified and transected just distal to the
bifurcation of the IMA and the LCA in the low ligation
group; c) the IMA was transected at its origin from the
aorta in the high ligation group; d) upward dissection of
the mesentery along the ascending branch of the LCA was
performed, and the inferior mesenteric vein (IMV) was
clipped and transected in this area; e) medial to lateral
dissection was performed, followed by colonic splenic
flexure dissection to facilitate the complete mobilization

of the descending colon; f) downward dissection of the
presacral facia was performed until the cut reached the
pelvic floor, with preservation of the paired hypogastric
nerves and pelvic autonomic nerve plexus; g) the peritoneal
reflection was incised laterally and followed anteriorly,
and the rectum was separated circumferentially from the
vagina/prostate up to the level of the levator muscles with
the plane of Denonvilliers’ fascia; h) transection of the
distal rectum was performed with a 60 mm endoscopic
linear stapler.
The vascular supply of the proximal colon segment was
macroscopically checked after the specimen was removed
from the Pfannenstiel incision using an Alexis wound
protector (Applied Medical Resources Corporation,
California, CA, USA) to prevent wound infection in all
patients. Transsection and anastomosis were performed
after adequate blood supply was observed. Bowel
continuity was reconstructed by end-to-end colorectal
anastomosis with doublestapled technique by using a 31-
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mm EEA circular stapler (Medtronic Inc., Minneapolis,
MN, USA). Anastomosis completeness was checked
withthe air-water test and macroscopic examinations of
donuts were made with a circular stapler in all patients.
Diverting loop ileostomy was performed on all patients.
2.3. End points
The end points were made up of the postoperative
anastomotic stricture rate, overall morbidity, postoperative
morbidity, the length of hospital stay, the number of
harvested lymph nodes, the number of metastatic lymph
nodes, the rate of metastatic lymph nodes to harvested
lymph nodes, the 2-year overall survival (OS) and diseasefree survival (DFS) rates, and determination of factors
affecting overall and disease-free survival.
2.4. Statistical analysis
Statistical analysis was made using IBM’s SPSS Statistics for
Windows, Version 23.0 (IBM Corp., Armonk, Newyork,
NY, USA). Data are expressed as n(%), mean±standard
deviation (range) or median (range), as appropriate.
Normality assumptions were controlled by the Shapiro–
Wilk test. Categorical data were analyzed by the Pearson
chi-square test or Fisher’s exact test. The differences
between the 2 groups were evaluated with a Student’s t-test
for normally distributed data or with the Mann–Whitney
U test for nonnormally distributed data. OS and DFS were
estimated using the Kaplan–Meier method. The log-rank
test was used to compare survival differences. A univariate
Cox proportional hazards regression model was used to
identify prognostic factors. The variables which showed
significant association with OS or DFS in the univariate
analyses were further tested in the multivariate model. The
hazard ratio, with corresponding 95% confidence intervals
(95% CIs), was reported. A P-value of less than 0.05 was
considered statistically significant.
3. Results
3.1. Patients characteristics
Grouped as 38 patients in the low ligation group and 39 in
the high ligation group, the clinical and pathological data
of the 77 patients with rectal cancer who underwent nCRT
followed by robotic surgery are summarized in Table 1.
The median age of patients in the high ligation group and
low ligation group was 61.6 years (range: 35–79 years) and
62.5 years (range: 43–82 years), respectively. In the high
ligation group, 25 of the patients were male (64.1%) and 14
(35.9%) were female. In the low ligation group, 21 of the
patients were male (55.3%) and 17 were female (44.7%).
Six patients (15.4%) in the high ligation group and 7
patients (18.4%) in the low ligation group had previous
abdominal surgery. Twenty-four patients (61.5%) in the
high ligation group (17 hypertension with and/or 4 with
diabetes mellitus) and 19 (50%) in the low ligation group
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(15 with hypertension and/or 11 with diabetes mellitus)
had comorbidities. Preoperative nCRT was administered
to all of the patients because all patients had stage 2 or 3
locally advanced rectum tumors during the preoperative
period. There were no statistically significant differences
between the high ligation group and the low ligation group
regarding age, sex, previous abdominal surgery, nCRT,
and comorbidities. However, diabetes mellitus was more
common in the low ligation group (28.9% versus 10.3%),
and the difference between the 2 groups was statistically
significant in the subgroup analysis (P = 0.038).Mean
time interval difference between nCRT completion and
the robotic surgery in the high ligation group and the low
ligation group was not significant (61 days and 60 days,
respectively) (P= 0.495).
The ASA scores of all patients were I and II. The
number of patients with ASA I in the high and low ligation
groups was 14 (35.9%) and 19 (50%), respectively. The
number of the patients with ASA II in the high ligation
group and the low ligation group was 25 (64.1%) and
19(50%), respectively. The ASA scores of the high ligation
group and low ligation group were similar (P = 0.211 for
ASA I and P = 0.136 for ASA II). Median length of hospital
stay was 6 (4–16) days for the high ligation group and 5
(4–17) days for the low ligation group. The difference was
statistically significant in favor of the low ligation group
(P = 0.011).The mean followup time for the high ligation
group and the low ligation group was similar [33.03 ±
6.9 (range: 24–48) weeks and 33.76 ± 6.6 (range: 24–46)
weeks, respectively; P = 0.854].
3.2. Association of level of ligation with postoperative
complications
The postoperative complications in groups are
summarized in Table 2. Postoperative complications
were detected in 19 patients [12 (30.8%) in the high
ligation group and 7 (18.4%) in the low ligation group].
The difference was also not statistically significant (P =
0.209). In the subgroup analysis, the differences were
not significant for anastomosis leak, rectovaginal fistula,
surgical site infection, postoperative bleeding, ureteral
injury, postoperative ileus, and pulmonary embolism (P =
0.999, P = 0.240, P = 0.999, P = 0.999, P = 0.999, P = 0.999,
and P = 0.494, respectively).
However, in the high ligation group, anastomosis
stricture was observed in 11 (28.2%) patients in the case
of colonoscopies performed before the closure of loop
ileostomy, while anastomosis stricture was observed in
1 (2.6%) patient in the low ligation group. The difference
was statistically significant (P = 0.002).
Six of the 11 anastomosis stricture patients in the high
ligation group were treated with colonoscopic balloon
dilatation, one patient was treated with digital dilatation,
and 4 patients needed surgical intervention. Stapled

GÖMCELİ and ARAS / Turk J Med Sci
Table 1. Characteristics of all patients in the study.
High ligation
(n: 39)

Low ligation
(n: 38)

P

Age (median) (range)

61.6 ± 10.8(35–79)

62.5 ± 8.9(43–82)

0.705

Sex
Male/female

25(64.1%)/14(35.9%)

21(55.3%)/17(44.7%)

0.429

Previous abdominal surgery

6(15.4%)

7(18.4%)

0.722

Comorbidities

24(61.5%)

19(50%)

0.308

HT

17(43.6%)

15(39.5%)

0.714

DM

4(10.3%)

11(28.9%)

0.038

Neoadjuvant CRT

39(100%)

38(100%)

0.999

Time interval between NCRT completion and
robotic surgery (day, mean) (range)

61(56-66)

60(57–63)

0.495

I

14 (35.9%)

19 (50%)

0.211

II

25 (64.1%)

19 (50%)

0.136

Length of hospital stay (median)

6 (4–16)

5(4–17)

0.011

≤2

18 (46.2%)

20 (52.6%)

0.570

>2

21 (53.8%)

18 (47.4%)

0.295

0

27 (69.2%)

20 (52.6%)

0.324

1

7 (17.9%)

11 (28.9%)

0.528

2

5 (12.8%)

7 (18.4%)

0.356

0

3 (7.7%)

1 (2.6%)

0.301

1

13 (33.3%)

13 (34.2%)

0.518

2

11 (28.2%)

6 (15.8%)

0.437

3

12 (30.8%)

18 (47.4%)

0.217

Tumor localization from anal verge (cm)

8 (5–11)

8 (4–11)

0.876

Number of harvested lymph node (mean) (range)

14.10 ±3.2 (8–22)

14.08 ± 4.9 (5–25)

0.980

Number of metastatic lymph node (mean) (range)

1.08 ± 2.2/0(0-8)

1.79 ± 3.1/0 (0–13)

0.124

Metastatic lymph node / harvested lymph node ratio

7%

10%

0.135

ASA

T Stage (yp)

N Stage (yp)

AJCC Stage (yp)

anastomosis could be applied to 1 of the 4 patients who
underwent surgery, while resection anastomosis could
not be done to the other 3 due to the long segment of
the stricture line so, in the end, a colostomy had to be
performed. In the low ligation group, 1 patient with an
anastomosis stricture wastreated with digital dilatation.
Rectovaginal fistulas that developed in the high ligation
group were observed on the 23rd, 35th, and 50th day
following surgery. Anastomosis stricture was also observed
in 2 of these patients. After approximately 6 months of
follow-up, surgical treatment was needed due to lack of

improvement, despite all nonsurgical treatments (such as
discontinuation of oral intake and postponement of loop
ileostomy closure).
In the high ligation group, 1 of the 3 patients with
anastomosis leakage had undergone an end colostomy on
the 7th postoperative day, and 1 of the patients was treated
with primary suturing. In the other patient, anastomosis
leakage was treated with the interruption of oral feeding
without the need for surgical intervention. In the low
ligation group, 1 of the 2 patients with anastomosis leakage
had undergone an end colostomy on the 9th postoperative
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Table 2. Postoperative complications in the high ligation and the low ligationgroups.
High ligation
(n: 39)

Low ligation
(n: 38)

P

Postoperative complications

12 (30.8%)

7 (18.4%)

0.209

Anastomosis stricture

11 (28.2%)

1 (2.6%)

0.002

Anastomosis leak

3 (7.7%)

2 (5.3%)

0.999

Rectovaginal fistula

3 (7.7%)

0 (0%)

0.240

Surgical site infection

3 (7.7%)

2 (5.3%)

0.999

Postoperative bleeding

1 (2.6%)

1 (2.6%)

0.999

Ureteral injury

1 (2.6%)

0 (0%)

0.999

Postoperative ileus

1 (2.6%)

0 (0%)

0.999

Pulmonary embolism

0 (0%)

1 (2.6%)

0.494

day, and the other one was treated with the interruption
of oral feeding without the need for surgical intervention.
Ureteral injury in the high ligation group was treated
with the double-J ureteral stent placement.All other
postoperative complications were treated with medical
treatment without the need for surgical intervention.
3.3. Association of level of ligation with tumor
characteristics
Tumor characteristics of the groups were compared
(Table 1). The distances of the tumors from the anal
verge during preoperative colonoscopic assessment were
similar in the 2 groups (8 cm in both groups).The mean
number of harvested lymph nodes in the high ligation
group was 14.10 ± 3.2 (range: 8–22) and 14.08±4.9 (range:
5–25) in the low ligation group. There was no significant
difference between the 2 groups (P = 0.980). The difference
for the mean number of metastatic lymph nodes was not
statistically significant either in the high or the low ligation
group (P = 0.124) (1.08 (range: 0–8) and 1.79 (range 0–13),
respectively). The difference between the metastatic lymph
node to harvested lymph node ratio between the 2 groups
was not statistically significant (7% vs. 10%, P = 0.135). The
tumor stages of the 2 groups did not differ statistically, and
their T and N stages were equivalent, as well.
3.4. Survival benefit outcomes
OS was defined as the length of time from the operation to
death, and DFS was defined as the time from operation to
disease recurrence.
Survival outcomes and univariate/multivariate
analyses of factors affecting the survival outcomes were
compared (Tables 3 and 4, Figure 2). No deaths occurred
within 30 days in either group. It was determined that sex,
previous abdominal surgery, ASA score, and length of
hospital stay were not statistically significant in terms of
2-year OS and DFS. However, in the univariate analysis
of the patients’age, it was observed that it did not affect
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disease-free survival, while it did affect overall survival
(OR = 1.244; 95% CI = 1.099 to 1.41; P = 0.001). In the
subgroup analysis of comorbidities, hypertension was
found to be a determinant of overall survival (OR =
11.067; 95% CI = 1.361 to 90.02; P = 0.025). Similarly, only
postoperative bleeding was found to be a determinant of
disease-free survival in the univariate subgroup analysis
of postoperative complications (OR = 9.779; 95% CI =
2.173 to 44.011; P = 0.003).After analyzing pathological
data from all rectal cancers, our results showed that all T3,
T4, N1, N2, and stage 3 and above tumors significantly
determined DFS. However, only N2 tumors were found to
affect OS (Table 3).
When the dissected lymph nodes were evaluated in
the univariate analysis, the number of metastatic lymph
nodes and themetastatic lymph node/harvested lymph
node ratios were found to be significant for both OS and
DFS. However, the number of harvested lymph nodes was
significant only for DFS (Table 3).
There was no statistical difference between the high
ligation group and the low ligation group in the univariate
analysis for 2-year OS and DFS (OR = 1.146; 95% CI =
0.274 to 4.797; P = 0.950 and OR = 1.141; 95% CI = 0.564 to
2.308; P = 0.713, respectively). In the multivariate analysis
of all factors that are significant in the univariate analysis,
only patient age was found to be significant for OS.
Postoperative complications, T3, T4, N1, and N2 tumors
were found to be significant for DFS (Table 4, Figure 2).
4. Discussion
In rectal cancer surgery, studies comparing the clinical
and oncological outcomes of open surgery, laparoscopic
surgery, and robotic surgery are currently being carried
out, and recent studies have reported the potentially
significant benefits of robotic surgery for rectal cancer
[17–24]. The current robotic operative system has the
advantages of offering stable vision, 3-dimensional view,
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Table 3. Univariate analysis for OS and DFS (OS: overall survival; DFS: disease-free survival).
OS

DFS

HR (95%CI)

P

HR (95%CI)

P

1.244 (1.099–1.41)

0.001

1.016 (0.977–1.056)

0.424

Female

Reference

-

Reference

-

Male

1.146 (0.274–4.797)

0.852

1.571 (0.74–3.337)

0.240

Low ligation

Reference

-

Reference

-

High ligation

1.146 (0.274–4.797)

0.950

1.141 (0.564–2.308)

0.713

Previous abd. surgery

1.78 (0.359–8.825)

0.480

1.256 (0.515–3.063)

0.616

Comorbidities

6.024 (0.741–48.981)

0.093

1.12 (0.549–2.286)

0.756

HT

11.067 (1.361–90.02)

0.025

1.707(0.844–3.455)

0.137

DM

2.71 (0.647–11.348)

0.172

1.425 (0.637–3.188)

0.388

Postop. Ccomplications

1.805 (0.431–7.555)

0.419

2.073 (0.993–4.329)

0.052

Anastomosis stricture

0.733 (0.09–5.957)

0.771

0.492 (0.15–1.619)

0.243

Anastomosis leak

0.045 (0–8632.021)

0.617

0.466 (0.064–3.422)

0.453

Rectovaginal fistula

3.891 (0.477–31.725)

0.204

1.45 (0.346–6.085)

0.611

Surgical Ssite infection

0.045 (0–86.021)

0.617

2.523 (0.765–8.323)

0.129

Postop. bleeding

5.111 (0.629–41.55)

0.127

9.779 (2.173–44.011)

0.003

I

Reference

-

Reference

-

II

5.702 (0.701–46.363)

0.103

1.227 (0.595–2.527)

0.580

Length of hospital stay

0.847 (0.612-1.172)

0.316

1.038 (0.941–1.146)

0.455

≤2

Reference

-

Reference

-

>2

0.944 (0.236–3.773)

0.935

6.255(2.555–15.311)

<0.001

0

Reference

-

Reference

-

1

2.618 (0.369–18.588)

0.336

11.444 (4.087–32.045)

<0.001

2

8.392 (1.535–45.871)

0.014

32.31 (10.93–95.51)

<0.001

≤2

Reference

-

Reference

-

>2

4.833 (0.975–23.96)

0.054

15.714 (5.96–41.436)

<0.001

Tumor localization from anal verge

0.776 (0.522–1.154)

0.210

1.061 (0.871–1.291)

0.557

Number of harvested lymph nodes

1.153 (0.985-1.351)

0.076

1.211 (1.11–1.321)

<0.001

Number of metastatic lymph nodes

1.213 (1.036–1.42)

0.017

1.255 (1.165–1.351)

<0.001

Metastatic lymph node/harvested lymph node ratio

1.036 (1.003–1.069)

0.030

1.051 (1.035–1.067)

<0.001

Age
Sex

Study groups

ASA

T Stage

N Stage

AJCC Stage

and superior dexterity and precision of the movements
of the robotic arms. Hence, robotic surgery allows more
precise dissection in the pelvic cavity, thus increasing the
sphincter preservation rate, decreasing circumferential
resection margin (CRM) positivity, and reducing the

conversion rates in patients with low rectal cancer [25].
Similar advantages can even be gained in patients with
rectum cancer receiving nCRT before surgery [26].
The main issue under discussion is the adequacy
of oncological outcomes to be obtained as a result of
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Table 4.Multivariate analysis for OS and DFS (OS: overall survival; DFS: disease-free survival).
OS

DFS

HR (95%CI)

P

HR (95%CI)

P

Age

1.46 (1.127–1.89)

0.004

-

-

HT

7.06 (0.524–95.177)

0.141

2.18(0.914-5.201)

0.079

I

Reference

-

-

-

II

0.034 (0.001–1.813)

0.096

-

-

Postop. Complications

-

-

2.330 (1.019–5.327)

0.045

≤2

-

-

Reference

-

>2

-

-

4.644 (1.669–12.918)

0.003

0

Reference

-

Reference

-

1

1.375 (0.156–12.137)

0.774

8.026 (2.663–24.185)

<0.001

2

0.76 (0.014–41.462)

0.893

9.393 (1.961–45)

0.005

Number of harvested lymph nodes

1.203 (0.962–1.505)

0.105

1.059 (0.93–1.207)

0.386

Number of metastatic lymph nodes

1.24 (0.707–2.174)

0.453

1.05 (0.892–1.234)

0.558

ASA

T Stage

N Stage

minimally invasive surgery. A randomized trial, COREAN,
which compared open versus laparoscopic surgery for mid
to low rectal cancer after neoadjuvant chemoradiotherapy,
revealed no difference in the rate of CRM positivity rates
of completeness of mesorectal resection, and no difference
in 3-year disease-free survival [27,28]. A randomized,
international, multicenter study comparing the outcomes
of laparoscopic and conventional resection of rectal
carcinoma, The European COLOR II trial, resulted
in similar safety, resection margins, completeness of
resection, and 3-year locoregional recurrence and survival
rates [29,30].
In some studies about robotic and laparoscopic surgery
applications for rectal cancer, there was no difference in
operation time, complication, and leak rates. The quality
of the TME specimen was acceptable in both groups, and
there were more complete specimens in the robotic group
[31]. Moreover, in some studies, the conversion rate was
significantly lower for the robotic group with a better DFS
compared with the laparoscopic group [32].
Another issue is in regard to the completeness of TME,
which was studied in a metaanalysis by Milone et al. in
2019. It was concluded in the analysis of 1520 procedures
that completed TME showed a statistically significant
difference in favor of robotic surgery [33].
Likewise, the number of harvested lymph node
metastasis is a crucial factor in predicting the prognoses of
colorectal cancer patients. At least 12 lymph nodes should
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be examined for each surgical specimen, as recommended
in the AJCC/UICC guidelines. However, it is very difficult
to reach this recommended number of lymph nodes
after nCRT, and the number of harvested lymph nodes
significantly decrease after preoperative nCRT with
the median number of lymph nodes at 4 to 14 [34,35].
In this context, which level of IMA dissection must be
performed in order to reach the recommended number
of lymph nodes in colorectal cancer surgery has become a
current issue. Consequently, the high or low ligation level
of IMA remains controversial today. In many studies, it
has been reported that high ligation of IMA will result in
more satisfactory survival and adequate staging [36–38].
However, low ligation of the IMA with the preservation
of the LCA has recently been suggested by some surgeons
[39–41]. It has also been claimed that the high ligation
technique can reduce blood flow in the colon and then
cause intestinal ischemia, and that this eventually may lead
to anastomosis leakage. Moreover, 5 retrospective cohort
studies and 2 randomized clinical trials showed that the
level of ligation had no impact on oncologic outcomes
[8,42,43].
All factors such as open or minimally invasive surgery,
the number of harvested lymph nodes, the number of
metastatic lymph nodes, the level of IMA ligating, tumor
stage, and nCRT appear to affect oncological and clinical
outcomes. However, studies need to be standardized in
order to evaluate these factors. However, laparoscopic
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Figure 2. Kaplan–Meier estimates of overall survival and disease-free survival for the low and high ligation groups (A1, A2) for invasion status of tumor “T” (B1, B2), for
lymph node status of tumor “N” (C1, C2), and for tumor stages (D1, D2).
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and robotic surgery, patients with or without nCRT, and
sigmoid or rectum cancers are evaluated together in most
studies. In particular, performing a standard surgery is
mandatory in terms of standard study results.
In this study, all parameters that may affect the study
results tried to be standardized while evaluating the clinical
and oncological results of IMA high or low ligation.
For example, age, sex, previous abdominal surgery,
comorbidities, diverting loop ileostomy application,
nCRT status, time from nCRT to surgery, and ASA scores
were all standardized. Additionally, a single surgeon
experienced in robotic colorectal surgery performed all
of the operations. Furthermore, in this study, there was
no difference in the high ligation versus the low ligation
group for the TNM stages, the number of harvested lymph
nodes, the number of metastatic lymph nodes, and the
ratio of metastatic lymph nodes to harvested lymph nodes.
When the clinical results of high and low IMA ligation
were evaluated after the standardization of all of these
clinical parameters, a significantly increased anastomosis
stricture was observed in the high ligation group.
Although some studies suggest that the more
extensive resection of mesenteric lymphatic drainage
that is associated with high ligation increases the survival
rate and reduces the recurrence rate [44–46], our study
showed no significant differences with regard to 2-year OS
and DFS between high or low ligation of the IMA, as has
been shown in several other studies [47,48].
Some authors have suggested that the status of the
lymph nodes around the IMA root is the most important
determinant of DFS [49],but Adachi et al. analyzed lymph
node metastasis distribution along the IMA and indicated
that only 0.7% of the patients had a positive lymph node at
the root of the IMA[50].Therefore, as in our study and in
some other studies [51,52], adequate oncologic outcomes
can be achieved by low ligating IMA with robotic rectal
cancer surgery.
Studies comparing the high or low binding of IMA
have generally evaluated anastomosis leakage as a study
end point [9,40,53]. However, evaluation of stricture
development in anastomosis may be an important
endpoint, because the stricture, as in our study, may be
due to the lack of blood flow that develops after the high
binding of IMA. This has been shown with laser Doppler
flowmetry inthe study of Komen et al. [54]. This lack of
blood flow may also cause anastomosis leaks. In addition,
it is also very difficult to manage these anastomosis

strictures. Although some authors suggest the resection
of this area with a circular stapler for the treatment of
anastomosis strictures [55], this may not always be possible
since stricture often includes a long colon segment, as seen
in our 3 patients in the high ligation group; in addition,
sometimes surgery could have to be terminated with an
end colostomy, especially in anastomoses located below.
Also, it should be observed that diversion colitis might
contribute to the high anastomosis stricture rate (28.2%)
in the high ligation group in our study. However, in
order to standardize the cases, patients without diversion
ileostomy were excluded from this study. Therefore,
the effect of diversion colitis is valid for both groups.
Moreover, the similar anastomosis leak rate between the
2 groups reveals more clearly the effect of anastomosis
blood flow on the development of stricture because, even
if anastomosis leakage does not develop, low blood flow
in the high ligation group may be the cause of stricture in
long-term follow-up.
It may be claimed that the high binding of IMA can
ensure a tension-free colorectal anastomosis. However,
such a problem can be resolved if the IMV is ligated at the
level of the lower border of the pancreas, and if the lateral
attachments of the descending colon are mobilized to the
level of the splenic flexure, as Liang et al. have described
[51].
Another approach for anastomosis safety is
intraoperative assessment of perfusion at the site of
anastomosis with indocyanine green (ICG). In some
studies, more anastomosis leakage was observed in
the group that was detected to have poor perfusion
onfluorescence angiography via ICG [56–58]. However,
Boni et al. compared patients undergoing low anterior
resection with or without ICG angiography, and they
observed no significant differences between the 2 groups
in terms of the anastomosis leak.
In
conclusion,
in
robotic
low
anterior
resection,performed by experienced surgeons, the low
ligation technique of the IMA can reduce the rate of
anastomosis stricture and provide similar oncological
results as the high ligation technique.
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